A Aralex Aachen research explorer

February 23, 2024 article Open access

First-in-Class Humanized Antibody against Alternatively Spliced Tissue Factor Augments Anti-Metastatic Efficacy of Chemotherapy in a Preclinical Model of Pancreatic Ductal Adenocarcinoma

International Journal of Molecular Sciences

DOI: 10.3390/ijms25052580 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 0 stored of 0

References 2

Therapy-Naive and Radioresistant 3-Dimensional Pancreatic Cancer Cell Cultures Are Effectively Radiosensitized by β1 Integrin Targeting
2021 International Journal of Radiation Oncology*Biology*Physics article Medicine Pancreatic and Hepatic Oncology Research Open access

8

citations
A First-In-Class, Humanized Antibody Targeting Alternatively Spliced Tissue Factor: Preclinical Evaluation in an Orthotopic Model of Pancreatic Ductal Adenocarcinoma
2021 Frontiers in Oncology article Medicine Pancreatic and Hepatic Oncology Research Open access

8

citations

2 results